1. Home
  2. SERV vs CATX Comparison

SERV vs CATX Comparison

Compare SERV & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Serve Robotics Inc.

SERV

Serve Robotics Inc.

HOLD

Current Price

$4.37

Market Cap

372.8M

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$2.56

Market Cap

355.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SERV
CATX
Founded
2017
1983
Country
United States
United States
Employees
380
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.8M
355.0M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
SERV
CATX
Price
$4.37
$2.56
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$17.67
$12.11
AVG Volume (30 Days)
2.7M
1.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$207,545.00
N/A
Revenue This Year
$920.26
N/A
Revenue Next Year
$184.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
92.49
N/A
52 Week Low
$4.17
$1.96
52 Week High
$18.64
$6.16

Technical Indicators

Market Signals
Indicator
SERV
CATX
Relative Strength Index (RSI) 43.13 N/A
Support Level $4.31 N/A
Resistance Level $5.88 N/A
Average True Range (ATR) 0.20 0.00
MACD 0.01 0.00
Stochastic Oscillator 37.20 0.00

Price Performance

Historical Comparison
SERV
CATX

About SERV Serve Robotics Inc.

Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. The Segment derives revenue from (i) services via the Companies robot fleet, including delivery, branding and experiential services, (ii) access to software developed for the robot fleet, including certain autonomous capabilities, and (iii) access to data collected by the robot fleet, including navigation-related data. The majority of the revenue is derived from robot delivery services and food delivery platforms.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: